Quo vadis motor neuron disease?

Area of Science:

• Neurodegenerative diseases
• Neurobiology
• Neurology

Background:

• Motor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a progressive, fatal neurodegenerative disorder.
• Current understanding of MND's etiology and pathogenesis is incomplete, with no definitive cure available.
• Riluzole, a glutamate antagonist, is the sole FDA-approved therapy, offering modest survival benefits.

Purpose of the Study:

• To provide a comprehensive overview of the motor system's anatomy and its dysfunction in MND.
• To summarize current knowledge on MND pathogenesis derived from pathological, genetic, and animal studies.
• To propose strategies for accelerating the discovery of novel therapeutic targets for MND.

Main Methods:

• Review of existing literature on motor system anatomy and MND.
• Analysis of pathological findings in MND.
• Examination of genetic factors implicated in MND.
• Evaluation of insights from animal models of MND.

Main Results:

• The review details the structural and functional organization of the motor system.
• It highlights key clinical features and progression patterns of MND.
• Insights from diverse research avenues underscore the complexity of MND.

Conclusions:

• There is a critical unmet need for effective treatments for MND.
• Understanding disease mechanisms is paramount for developing novel therapeutic strategies.
• A multi-faceted approach combining pathological, genetic, and model system insights is crucial for advancing MND research.